Sai Parenteral's Ltd. IPO Details – Price, Date, GMP & Analysis

Incorporated in 2001, Sai Parenteral's Ltd. is a diversified pharmaceutical formulations company specializing in research, development, and manufacturing. It operates in two segments: Branded Generic Formulations and CDMO products for domestic and international markets. The product portfolio includes various therapeutic areas such as cardiovascular, neuropsychiatry, anti-diabetic, respiratory health, and more, with offerings in multiple dosage forms. The company serves a wide customer base, including government agencies, pharmaceutical companies, and hospitals in India. In FY 2023, it began exports after acquiring two accredited facilities in Hyderabad, supplying to markets in Australia, New Zealand, Southeast Asia, the Middle East, and Africa. Sai Parenteral's operates five manufacturing facilities in India, with four in Hyderabad and one in Ongole, Andhra Pradesh. As of August 31, 2025, the company employed 277 full-time employees.